Suppr超能文献

饮食组成与非酒精性脂肪性肝病管理中的体重减轻无关。

Dietary Composition Independent of Weight Loss in the Management of Non-Alcoholic Fatty Liver Disease.

机构信息

Division of Gastroenterology, Department of Medicine, University of Alberta, Edmonton, AB T6G 2X8, Canada.

Cirrhosis Care Clinic and CEGIIR, University of Alberta, Edmonton, AB T6G 2X8, Canada.

出版信息

Nutrients. 2017 Jul 26;9(8):800. doi: 10.3390/nu9080800.

Abstract

Poor dietary composition is an important factor in the progression of non-alcoholic fatty liver disease (NAFLD). The majority of NAFLD patients follow diets with overconsumption of simple carbohydrates, total and saturated fat, with reduced intake of dietary fiber and omega-3 rich foods. Although lifestyle modifications including weight loss and exercise remain the keystone of NAFLD management, modifying dietary composition with or without a calorie-restricted diet may also be a feasible and sustainable strategy for NAFLD treatment. In the present review article, we highlight the potential therapeutic role of a "high quality healthy diet" to improve hepatic steatosis and metabolic dysfunction in patients with NAFLD, independent of caloric restriction and weight loss. We provide a literature review evaluating the evidence behind dietary components including fiber-, meat- and omega-3-rich diets and, pending further evidence, we concur with the EASL-EASD-EASO Clinical Guidelines recommendation of the Mediterranean diet as the diet of choice in these patients.

摘要

不良的饮食结构是非酒精性脂肪性肝病(NAFLD)进展的一个重要因素。大多数 NAFLD 患者的饮食中存在简单碳水化合物、总脂肪和饱和脂肪摄入过多,膳食纤维和富含 ω-3 的食物摄入减少的问题。尽管包括减肥和运动在内的生活方式改变仍然是 NAFLD 管理的基石,但在限制热量摄入的饮食基础上调整饮食结构也可能是治疗 NAFLD 的一种可行且可持续的策略。在本综述文章中,我们强调了“高质量健康饮食”在改善 NAFLD 患者肝脂肪变性和代谢功能障碍方面的潜在治疗作用,这种作用不依赖于热量限制和体重减轻。我们对饮食成分的相关文献进行了评估,包括富含纤维、肉类和 ω-3 的饮食,在有更多证据之前,我们同意 EASL-EASD-EASO 临床指南推荐地中海饮食作为这些患者的首选饮食。

相似文献

4
Health benefits of Mediterranean diet in nonalcoholic fatty liver disease.
Expert Rev Gastroenterol Hepatol. 2018 Sep;12(9):873-881. doi: 10.1080/17474124.2018.1503947. Epub 2018 Aug 1.
6
Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.
World J Gastroenterol. 2014 Dec 7;20(45):16831-40. doi: 10.3748/wjg.v20.i45.16831.
7
Beyond Body Weight-Loss: Dietary Strategies Targeting Intrahepatic Fat in NAFLD.
Nutrients. 2020 May 6;12(5):1316. doi: 10.3390/nu12051316.
8
Lifestyle Modifications in Non-Alcoholic Fatty Liver Disease and Non- Alcoholic Steatohepatitis.
Curr Vasc Pharmacol. 2018;16(3):239-245. doi: 10.2174/1570161115666170621080835.
10
Mediterranean diet and non-alcoholic fatty liver disease: new therapeutic option around the corner?
World J Gastroenterol. 2014 Jun 21;20(23):7339-46. doi: 10.3748/wjg.v20.i23.7339.

引用本文的文献

2
Effects of Exercise Intervention in Subjects with Metabolic Dysfunction-Associated Steatotic Liver Disease.
J Obes Metab Syndr. 2025 Jul 30;34(3):239-252. doi: 10.7570/jomes25028. Epub 2025 Jul 11.
6
Gut microbiota involvement in the effect of water-soluble dietary fiber on fatty liver and fibrosis.
Biosci Microbiota Food Health. 2025;44(1):49-57. doi: 10.12938/bmfh.2024-046. Epub 2024 Aug 21.
7
The association between vitamin E intake and hepatic steatosis in general and obese populations.
Nutr Metab (Lond). 2024 Jul 30;21(1):57. doi: 10.1186/s12986-024-00830-y.
8
Validation of adherence prediction system for lifestyle interventions in nonalcoholic fatty liver disease.
World J Gastroenterol. 2024 May 28;30(20):2629-2632. doi: 10.3748/wjg.v30.i20.2629.

本文引用的文献

1
Perspectives on Nonalcoholic Fatty Liver Disease: An Overview of Present and Future Therapies.
J Clin Transl Hepatol. 2017 Mar 28;5(1):67-75. doi: 10.14218/JCTH.2016.00061. Epub 2017 Mar 20.
4
Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids.
Clin Nutr. 2018 Feb;37(1):37-55. doi: 10.1016/j.clnu.2017.01.006. Epub 2017 Jan 19.
5
Non-pharmacological interventions in non-alcoholic fatty liver disease patients.
Liver Int. 2017 Jan;37 Suppl 1:90-96. doi: 10.1111/liv.13311.
6
Comparisons of dietary intake in Japanese with non-alcoholic fatty liver disease and type 2 diabetes mellitus.
J Clin Biochem Nutr. 2016 Nov;59(3):215-219. doi: 10.3164/jcbn.16-7. Epub 2016 Aug 19.
9
Metabolic aspects of adult patients with nonalcoholic fatty liver disease.
World J Gastroenterol. 2016 Aug 21;22(31):7006-16. doi: 10.3748/wjg.v22.i31.7006.
10
Adherence to the Dietary Approaches to Stop Hypertension (DASH) and risk of Nonalcoholic Fatty Liver Disease.
Int J Food Sci Nutr. 2016 Dec;67(8):1024-9. doi: 10.1080/09637486.2016.1210101. Epub 2016 Jul 19.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验